Novo Nordisk is committed to the fight against diabetes. We know that we are not simply treating diabetes. We are helping people live better lives. We understand diabetes is just a part of a person - not what defines them. This understanding is behind every decision or action we take and fuels our passion for changing the perception, treatment and future of diabetes for good.

We know that the diabetes pandemic has to be fought on all fronts. We believe that by raising awareness about the risks, symptoms and complications of the condition we can work together to break the curve.

Founded in 1923 out of a passion to help people with diabetes, our aspiration is to improve awareness, access, prevention, detection and treatment and ultimately to find a cure. Our culture is built on continuous improvement, balancing compassion with competitiveness, and a commitment to collaborate with everyone who shares our goals.

Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. We have the broadest diabetes product portfolio in the industry and continue to make the largest investment in research and development of new products compared to others in the industry.